Clinical Trials Directory

Trials / Unknown

UnknownNCT04463121

Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

Pressure-Volume (PV) Measurements for Evaluating the Changes in the Ventricular Preload and Autonomic Nervous System Using BackBeat Medical Cardiac Neuromodulation Therapy (CNT) Signals in an Acute Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
BackBeat Medical Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This investigation will evaluate the effect of RV pacing lead position on cardiac function and the modulation of the autonomic nervous system with Cardiac Neuromodulation Therapy (CNT) pacing signals. The study will be performed acutely prior to a pacemaker implant.

Detailed description

Subjects indicated for a dual chamber pacemaker implant or replacement who are not 100% dependent on right ventricular pacing may be eligible to participate in the study. This investigation will evaluate the effect of RV pacing lead position on cardiac function and the modulation of the autonomic nervous system using Cardiac Neuromodulation Therapy (CNT) pacing signals at different positions of the RV pacing lead. A standard conductance catheter will be introduced through the femoral artery and advanced into the left ventricle to measure cardiac volumes and pressure. Arterial blood pressure will be measured from the other femoral artery with an additional sheath. The Moderato® IPG will be used to generate Cardiac Neuromodulation Therapy (CNT) signals and deliver them to the patient through the cable and leads. A range of CNT signal parameters will be used to assess the effect on sympathetic activity at different positions of the RV pacing lead. Ventricular pressure and volume readings from the conductance catheter and arterial pressure readings will be recorded and analyzed to assess the effect of CNT signals on cardiac function, sympathetic activity and blood pressure. The effects of CNT signal over a range of parameter settings will be studied for the different RV lead positions.

Conditions

Interventions

TypeNameDescription
DEVICEModerato IPG's CNT pacing signalsAssesment of cardiac function and sympatheric activity will be obtained simultaneously
DEVICECD Leycom Pressure/Volume Combination CathetersSimultaneous recording of the Pressure, Volume measurements and ECG signals will be done for constant monitoring of intra-ventricular pressure and volume.

Timeline

Start date
2020-08-07
Primary completion
2023-03-31
Completion
2023-07-31
First posted
2020-07-09
Last updated
2022-09-19

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT04463121. Inclusion in this directory is not an endorsement.